Latest Breaking News On - Could change - Page 3 : vimarsana.com

The Michael J. Fox Foundation for Parkinson's Research (MJFF), confirms the most significant breakthrough yet in the search for a Parkinson's biomarker: a biological test for Parkinson's disease that demonstrates high diagnostic accuracy, differentiates molecular subtypes and detects disease in individuals before cardinal movement symptoms arise. The new test, known as the alpha-synuclein seed amplification assay (?Syn-SAA), heralds the revolutionary ability for research to define Parkinson's disease biologically, offering a critical tool for clinical trial design and assessment of treatment effects, and for early detection of disease pathology.

United statesSteve ballmerLily safraLuis conchaJames parkinsonAndrew siderowfMichaelj foxKenneth marekTeam foxMichaelj fox foundation for parkinson researchMichaelj fox foundationInstitute for neurodegenerative disordersEdmondj safra foundationParkinson progression markers initiativeFarmer family foundationMovement disorders center